Back to Search
GINA MILONE, MD
MD
Obstetrics & Gynecology Physician
NPI: 1548792195IndividualAccepts Medicare
Specialties, Licenses & Credentials
Maternal & Fetal Medicine Physician
Obstetrics & Gynecology — Maternal & Fetal Medicine
Code: 207VM0101X
171779(CA)
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
171779(CA)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Class of 2017
Research & Publications (20)
Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
PMID 17573610·Cytotherapy·2007
3-trial
Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.
PMID 17917963·Leuk Lymphoma·2007
3-trial
G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment.
PMID 12732880·Bone Marrow Transplant·2003
3-trial
Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.
PMID 12613518·Leuk Lymphoma·2002
3-trial
[Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
PMID 10835708·Medicina (B Aires)·2000
8-other
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants.
PMID 19584823·Bone Marrow Transplant·2010
4-observational
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family.
PMID 18596743·Leukemia·2009
8-other
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.
PMID 19322205·Leukemia·2009
4-observational
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
PMID 18945964·Blood·2009
3-trial
Is assessment of surface CD38 expression worthwhile as a prognostic factor in chronic lymphocytic leukemia patients?
PMID 18534062·Hematology·2008
8-other
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
PMID 18664623·Blood·2008
4-observational
Comparison of twin and autologous transplants for multiple myeloma.
PMID 18804041·Biol Blood Marrow Transplant·2008
3-trial
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
PMID 18195095·Blood·2008
3-trial
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
PMID 18804043·Biol Blood Marrow Transplant·2008
4-observational
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.
PMID 18084335·Bone Marrow Transplant·2008
4-observational
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.
PMID 17331132·Eur J Haematol·2007
3-trial
Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment.
PMID 17382258·Biol Blood Marrow Transplant·2007
3-trial
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection.
PMID 17529996·Bone Marrow Transplant·2007
3-trial
Treatment of refractory chronic GVHD with rituximab: a GITMO study.
PMID 17549053·Bone Marrow Transplant·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 333 City Blvd W Ste 1400
Orange, CA 92868 - Phone
- (714) 456-6807
Quick Facts
- NPI
- 1548792195
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile